Haleon Revenue

Haleon had revenue of 5.60B GBP in the half year ending June 30, 2026, a decrease of -1.62%. This brings the company's revenue in the last twelve months to 11.15B, up 1.21% year-over-year. In the year 2025, Haleon had annual revenue of 11.03B, down -1.81%.

Revenue (ttm)

11.15B

Revenue Growth

+1.21%

P/S Ratio

2.92

Revenue / Employee

454.53K

Employees

24,535

Market Cap

32.54B

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.03B	-203.00M	-1.81%
Dec 31, 2024	11.23B	-69.00M	-0.61%
Dec 31, 2023	11.30B	444.00M	4.09%
Dec 31, 2022	10.86B	1.31B	13.76%
Dec 31, 2021	9.55B	-347.00M	-3.51%
Dec 31, 2020	9.89B	1.41B	16.65%
Dec 31, 2019	8.48B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Hikma Pharmaceuticals	2.58B
HUTCHMED (China)	413.87M
ECO Animal Health Group	87.53M
Allergy Therapeutics	57.29M
Shield Therapeutics	36.93M
Venture Life Group	35.17M
Chill Brands Group	955.18K
Provexis	871.27K

Revenue Rankings

Haleon News

4 days ago - Haleon price target raised to 460 GBp from 430 GBp at Morgan Stanley - TheFly
6 days ago - ACCO vs. HLN: Which Stock Is the Better Value Option? - Nasdaq
10 days ago - Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US - Reuters
11 days ago - Haleon H1 Earnings Call Highlights - MarketBeat
11 days ago - Supplier Of Advil, Haleon Reports Half-Year 2026 Results - Nasdaq
11 days ago - Haleon Earnings Call Transcript: H1 2026 - Transcripts
11 days ago - Haleon Quarterly report: H1 2026 - Filings
11 days ago - Haleon Slides: H1 2026 - Filings

More News